• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

4-乙氧基-亚氨基-N'-甲氧基-吡咯烷-1-鎓-3-羧亚胺二氯化物

4-Ethoxy-imino-N'-methoxy-pyrrolidin-1-ium-3-carboximidamidium dichloride.

作者信息

Guo Qiang, Sun Lanying, Guo Huiyuan, Liu Mingliang

机构信息

Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing 100050, People's Republic of China.

出版信息

Acta Crystallogr Sect E Struct Rep Online. 2009 Feb 21;65(Pt 3):o580. doi: 10.1107/S1600536809004772.

DOI:10.1107/S1600536809004772
PMID:21582235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2968450/
Abstract

The title compound, C(8)H(18)N(4)O(2) (2+)·2Cl(-), contains two oxime groups. The methyl oxime group has a Z configuration, and the ethyl oxime group is disordered, with both Z and E configurations in occupancies of 0.840 (8) and 0.160 (8), respectively. In the crystal structure, there are a number of N-H⋯Cl hydrogen bonds.

摘要

标题化合物C(8)H(18)N(4)O(2)(2+)·2Cl(-)含有两个肟基。甲基肟基具有Z构型，乙基肟基无序，Z和E构型的占有率分别为0.840 (8)和0.160 (8)。在晶体结构中，存在大量N-H⋯Cl氢键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac1c/2968450/159102d1d504/e-65-0o580-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac1c/2968450/47b33401df23/e-65-0o580-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac1c/2968450/159102d1d504/e-65-0o580-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac1c/2968450/47b33401df23/e-65-0o580-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac1c/2968450/159102d1d504/e-65-0o580-fig2.jpg

相似文献

1
4-Ethoxy-imino-N'-methoxy-pyrrolidin-1-ium-3-carboximidamidium dichloride.4-乙氧基-亚氨基-N'-甲氧基-吡咯烷-1-鎓-3-羧亚胺二氯化物
Acta Crystallogr Sect E Struct Rep Online. 2009 Feb 21;65(Pt 3):o580. doi: 10.1107/S1600536809004772.
2
(1S,2S)-2-Carboxy-1-(3-pyridiniometh-yl)pyrrolidin-1-ium dichloride hemihydrate.（1S，2S）-2-羧基-1-（3-吡啶基甲基）吡咯烷-1-鎓二氯化物半水合物
Acta Crystallogr Sect E Struct Rep Online. 2008 Sep 17;64(Pt 10):o1960. doi: 10.1107/S160053680802922X.
3
N,N'-Bis[2-(methoxycarbonyl)ethyl]ethane-1,2-diammonium dichloride.N,N'-双[2-(甲氧基羰基)乙基]乙烷-1,2-二氯化铵
Acta Crystallogr Sect E Struct Rep Online. 2008 Jun 7;64(Pt 7):o1232. doi: 10.1107/S1600536808016565.
4
Bis{2-[3-(hy-droxy-imino-κN)butan-2-yl-idene]-N-methyl-hydrazinecarbothio-amide-κN,S}nickel(II) dichloride.二氯双{2-[3-(羟基亚氨基-κN)丁-2-亚基]-N-甲基肼甲硫酰胺-κN,S}镍(II)
Acta Crystallogr Sect E Struct Rep Online. 2012 Feb 1;68(Pt 2):m108-9. doi: 10.1107/S1600536811055395. Epub 2012 Jan 7.
5
1-(2-Hy-droxy-eth-yl)-4-[3-(2-trifluoro-methyl-9H-thioxanthen-9-yl-idene)prop-yl]piperazine-1,4-diium dichloride: the dihydro-chloride salt of flupentixol.1-（2-羟乙基）-4-[3-（2-三氟甲基-9H-噻吨-9-亚基）丙基]哌嗪-1,4-二氯化二铵：氟哌噻吨的二盐酸盐。
Acta Crystallogr Sect E Struct Rep Online. 2011 Aug 1;67(Pt 8):o2079-80. doi: 10.1107/S1600536811028182. Epub 2011 Jul 23.
6
4-{2-[3-(2-Ammonioacetamido)propanamido]ethyl}-1H-imidazol-3-ium dichloride.4-{2-[3-(2-氨基乙酰胺基)丙酰胺基]乙基}-1H-咪唑-3-鎓二氯化物
Acta Crystallogr Sect E Struct Rep Online. 2008 Nov 29;64(Pt 12):o2476. doi: 10.1107/S1600536808035952.
7
(S)-2-(2-Pyrrolidinio)-1H-benzimidazol-3-ium dichloride monohydrate.(S)-2-(2-吡咯烷基)-1H-苯并咪唑-3-鎓二氯化物一水合物
Acta Crystallogr Sect E Struct Rep Online. 2009 May 23;65(Pt 6):o1392. doi: 10.1107/S1600536809019084.
8
(E)-4-{[(3-Propyl-5-sulfanyl-idene-4,5-dihydro-1H-1,2,4-triazol-4-yl)imino]-meth-yl}-3-(p-tol-yl)-1,2,3-oxadiazol-3-ium-5-olate.（E）-4-{[（3-丙基-5-硫代亚基-4,5-二氢-1H-1,2,4-三唑-4-基）亚氨基]-甲基}-3-（对甲苯基）-1,2,3-恶二唑-3-鎓-5-醇盐
Acta Crystallogr Sect E Struct Rep Online. 2011 Oct 1;67(Pt 10):o2668-9. doi: 10.1107/S1600536811037287. Epub 2011 Sep 17.
9
2-Amino-5-ethoxy-carbonyl-4-methyl-thia-zol-3-ium chloride monohydrate.
Acta Crystallogr Sect E Struct Rep Online. 2009 Jul 4;65(Pt 8):o1753. doi: 10.1107/S1600536809024532.
10
Bis{N-ethyl-2-[3-(hy-droxy-imino-κN)butan-2-yl-idene]hydrazinecarbothio-amide-κN,S}nickel(II) dichloride.二氯双{N-乙基-2-[3-(羟基亚氨基-κN)丁-2-亚基]肼基甲硫酰胺-κN,S}镍(II)
Acta Crystallogr Sect E Struct Rep Online. 2012 Feb 1;68(Pt 2):m183-4. doi: 10.1107/S1600536811055383. Epub 2012 Jan 21.

本文引用的文献

1
tert-Butyl 4-carbamoyl-3-methoxy-imino-4-methyl-piperidine-1-carboxyl-ate.4-氨基甲酰基-3-甲氧基-亚氨基-4-甲基哌啶-1-羧酸叔丁酯
Acta Crystallogr Sect E Struct Rep Online. 2008 Nov 8;64(Pt 12):o2294. doi: 10.1107/S1600536808036106.
2
A short history of SHELX.SHELX简史。
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. doi: 10.1107/S0108767307043930. Epub 2007 Dec 21.
3
Therapeutic advances of new fluoroquinolones.新型氟喹诺酮类药物的治疗进展
Expert Opin Investig Drugs. 1998 May;7(5):761-83. doi: 10.1517/13543784.7.5.761.
4
Syntheses and biological evaluation of new fluoroquinolone antibacterials containing chiral oxiimino pyrrolidine.含手性肟基吡咯烷的新型氟喹诺酮类抗菌剂的合成与生物学评价
Bioorg Med Chem Lett. 2004 Mar 8;14(5):1273-7. doi: 10.1016/j.bmcl.2003.12.044.
5
Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde.作为喹诺酮类抗菌药物作用靶点的II型拓扑异构酶：从杰基尔博士变成海德先生
Curr Pharm Des. 2001 Mar;7(5):337-53. doi: 10.2174/1381612013398013.